Yi‐Rong Liu

2.2k total citations
44 papers, 1.6k citations indexed

About

Yi‐Rong Liu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yi‐Rong Liu has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 16 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Yi‐Rong Liu's work include Breast Cancer Treatment Studies (12 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Genomics and Diagnostics (6 papers). Yi‐Rong Liu is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer Genomics and Diagnostics (6 papers). Yi‐Rong Liu collaborates with scholars based in China, United States and Canada. Yi‐Rong Liu's co-authors include Yi-Zhou Jiang, Zhi-Ming Shao, Xin Hu, Ke‐Da Yu, Xiao‐En Xu, Xin Hu, Zhi‐Ming Shao, Xi Jin, Yue Gong and Peng Ji and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Cell.

In The Last Decade

Yi‐Rong Liu

43 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Rong Liu China 22 865 862 523 343 119 44 1.6k
Yi-Zhou Jiang China 23 681 0.8× 827 1.0× 648 1.2× 282 0.8× 172 1.4× 41 1.5k
Sara Akhavanfard United States 8 801 0.9× 504 0.6× 356 0.7× 248 0.7× 121 1.0× 15 1.4k
Hans Kristian Moen Vollan Norway 18 705 0.8× 573 0.7× 466 0.9× 213 0.6× 97 0.8× 25 1.3k
Craig P. Giacomini United States 16 780 0.9× 510 0.6× 417 0.8× 324 0.9× 177 1.5× 18 1.3k
Diego M. Marzese United States 25 1.2k 1.3× 608 0.7× 507 1.0× 276 0.8× 93 0.8× 75 1.7k
Katherine E. Hutchinson United States 19 972 1.1× 595 0.7× 920 1.8× 536 1.6× 201 1.7× 48 1.8k
Weiren Luo China 22 947 1.1× 596 0.7× 732 1.4× 198 0.6× 86 0.7× 42 1.7k
Ion Cristóbal Spain 22 1.1k 1.3× 489 0.6× 430 0.8× 177 0.5× 123 1.0× 58 1.5k
Yasuto Naoi Japan 23 661 0.8× 850 1.0× 662 1.3× 290 0.8× 276 2.3× 88 1.5k
Ana Cristina Vargas Australia 17 637 0.7× 472 0.5× 376 0.7× 254 0.7× 98 0.8× 36 1.1k

Countries citing papers authored by Yi‐Rong Liu

Since Specialization
Citations

This map shows the geographic impact of Yi‐Rong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Rong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Rong Liu more than expected).

Fields of papers citing papers by Yi‐Rong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Rong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Rong Liu. The network helps show where Yi‐Rong Liu may publish in the future.

Co-authorship network of co-authors of Yi‐Rong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Rong Liu. A scholar is included among the top collaborators of Yi‐Rong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Rong Liu. Yi‐Rong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yi‐Rong, Jinzhong Yang, Percy Lee, David P. Horowitz, & Tarita O. Thomas. (2025). Adaptative Radiation Therapy. 5(1). 1–13. 1 indexed citations
2.
Jiang, Yan, Yi‐Rong Liu, & Qian Yang. (2024). New insight for designing high-strength medium-entropy alloy with resistance to intermediate-temperature embrittlement by nitrogen-induced Ti-rich precipitation mechanism. Journal of Alloys and Compounds. 1008. 176805–176805. 1 indexed citations
3.
Liu, Yi‐Rong, et al.. (2023). SBRT vs. Y90. American Journal of Clinical Oncology. 47(3). 99–104. 2 indexed citations
4.
Liu, Yi‐Rong, et al.. (2023). A polarization image enhancement method for glioma. Frontiers in Neuroscience. 17. 1163701–1163701. 3 indexed citations
5.
Liu, Yi‐Rong, Honghui He, & Jian Wu. (2022). Differentiation of Human GBM From Non-GBM Brain Tissue With Polarization Imaging Technique. Frontiers in Oncology. 12. 863682–863682. 9 indexed citations
6.
Jin, Xi, Xiao‐En Xu, Yi-Zhou Jiang, et al.. (2019). The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Science Advances. 5(3). eaat9820–eaat9820. 96 indexed citations
7.
Zhao, Ya-Xin, Yi‐Rong Liu, Shaowei Xie, Yi-Zhou Jiang, & Zhi‐Ming Shao. (2019). A Nomogram Predicting Lymph Node Metastasis in T1 Breast Cancer based on the Surveillance, Epidemiology, and End Results Program. Journal of Cancer. 10(11). 2443–2449. 26 indexed citations
8.
Chen, Li, Yang Liu, Ling Yao, et al.. (2018). Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients. Nature Communications. 9(1). 1357–1357. 116 indexed citations
9.
Zheng, Yi-Zi, Hongjie Shen, Ding Ma, et al.. (2018). PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression. Cancer Research. 78(12). 3190–3206. 65 indexed citations
10.
Yao, Ling, et al.. (2018). Elevated miR-301a expression indicates a poor prognosis for breast cancer patients. Scientific Reports. 8(1). 2225–2225. 40 indexed citations
11.
Ma, Ding, Yi‐Rong Liu, Xin Hu, et al.. (2017). Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Scientific Reports. 7(1). 1134–1134. 5 indexed citations
12.
Gong, Yue, Yi‐Rong Liu, Peng Ji, Xin Hu, & Zhi-Ming Shao. (2017). Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Scientific Reports. 7(1). 45411–45411. 157 indexed citations
13.
Ma, Ding, Yi‐Zhou Jiang, Xiyu Liu, Yi‐Rong Liu, & Zhi‐Ming Shao. (2017). Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer. Breast Cancer Research and Treatment. 162(1). 39–48. 49 indexed citations
14.
Jiang, Yi-Zhou, Yi‐Rong Liu, Xiao‐En Xu, et al.. (2016). Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Cancer Research. 76(8). 2105–2114. 157 indexed citations
15.
Liu, Yi‐Rong, Yi-Zhou Jiang, Xiao‐En Xu, et al.. (2016). Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer. Clinical Cancer Research. 22(7). 1653–1662. 71 indexed citations
16.
Kuang, Xia-Ying, Yan Xu, Yi-Zi Zheng, et al.. (2016). Androgen receptor expression predicts different clinical outcomes for breast cancer patients stratified by hormone receptor status. Oncotarget. 7(27). 41285–41293. 52 indexed citations
17.
Liu, Yi‐Rong, Yi-Zhou Jiang, Xiao‐En Xu, et al.. (2016). Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Breast Cancer Research. 18(1). 33–33. 175 indexed citations
18.
Li, Jun-Jie, Yi‐Zhou Jiang, Yi‐Rong Liu, & Zhimin Shao. (2016). Identify high risk estrogen receptor-positive breast cancer patients for extended endocrine therapy. The Breast. 31. 173–180. 3 indexed citations
19.
Liu, Yi‐Rong, Yi-Zhou Jiang, Ke‐Da Yu, & Zhi‐Ming Shao. (2014). Different Patterns in the Prognostic Value of Age for Breast Cancer-Specific Mortality Depending on Hormone Receptor Status: A SEER Population-Based Analysis. Annals of Surgical Oncology. 22(4). 1102–1110. 26 indexed citations
20.
Liu, Yi‐Rong, et al.. (2013). Immediate Postmastectomy Breast Reconstruction Showed Limited Advantage in Patient Survival after Stratifying by Family Income. PLoS ONE. 8(12). e82807–e82807. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026